首页 > 最新文献

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru最新文献

英文 中文
[Interventional management of gastrointestinal and uterine bleeding in a patient with acute myeloid leukemia on induction therapy: case report]. 急性髓系白血病诱导治疗后消化道及子宫出血的介入治疗1例报告
Juan Sebastian Frias Ordoñez, Pablo Andrés Aux-Chaves, Wilmer Aponte Barrios, Fabian Enrique Neira-Escobar

Bleeding involves morbidity and mortality in patients with acute myeloid leukemia (AML) receiving induction therapy. The concomitant presentation of gastrointestinal and uterine bleeding is rare as described in the literature, and its approach is not standardized. The following is an illustration of a case in which interventionism was effective and safe. A 44-year-old woman recently diagnosed with acute myeloid leukemia was started on induction therapy with cytarabine and idarubicin and presented 10 days after its initiation with rectorrhagia, melena and abnormal uterine bleeding. Due to clinical deterioration, she was transferred to the intensive care unit and required massive transfusion therapy. She needed angiotomography of the abdomen, with a probable area of active bleeding in the thin loop of the proximal jejunum, as well as contrasted resonance of the abdomen and pelvis, with multiple myomatosis and endometrial thickening. Abdominal arteriography was performed, requiring supra-selective embolization of the distal branch of the superior mesenteric artery supplying the jejunum. Subsequently, selective aorto-iliac arteriography was performed, proceeding to complete occlusion with coils of uterine arteries bilaterally. Post-procedure evolution, without new signs of bleeding. Imaging control ruled out complications. She completed the induction scheme and was discharged on the 45th day of hospitalization to continue the chemotherapy maintenance scheme on an outpatient basis. Early arteriography and embolization are viable, safe and effective procedures both for the management of gastrointestinal and uterine bleeding in patients with AML receiving induction therapy.

出血涉及急性髓性白血病(AML)患者接受诱导治疗的发病率和死亡率。同时出现胃肠道和子宫出血在文献中是罕见的,其方法也不规范。以下是干预是有效和安全的一个例子。一名44岁的妇女最近被诊断为急性髓性白血病,她开始用阿糖胞苷和伊达柔比星诱导治疗,并在开始治疗10天后出现直肠出血、黑黑和子宫异常出血。由于临床恶化,她被转移到重症监护室,需要大量输血治疗。她需要对腹部进行血管断层扫描,发现空肠近端薄环处可能有活动性出血,同时对腹部和骨盆进行对比磁共振检查,发现多发性肌瘤病和子宫内膜增厚。进行腹部动脉造影,需要对供应空肠的肠系膜上动脉远端分支进行超选择性栓塞。随后,进行选择性主动脉-髂动脉造影,继续完成双侧子宫动脉线圈的闭塞。术后进展,没有新的出血迹象。影像学检查排除并发症。患者完成诱导方案,住院第45天出院,继续门诊化疗维持方案。对于接受诱导治疗的急性髓性白血病患者的胃肠道和子宫出血,早期动脉造影和栓塞是可行、安全、有效的治疗方法。
{"title":"[Interventional management of gastrointestinal and uterine bleeding in a patient with acute myeloid leukemia on induction therapy: case report].","authors":"Juan Sebastian Frias Ordoñez, Pablo Andrés Aux-Chaves, Wilmer Aponte Barrios, Fabian Enrique Neira-Escobar","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Bleeding involves morbidity and mortality in patients with acute myeloid leukemia (AML) receiving induction therapy. The concomitant presentation of gastrointestinal and uterine bleeding is rare as described in the literature, and its approach is not standardized. The following is an illustration of a case in which interventionism was effective and safe. A 44-year-old woman recently diagnosed with acute myeloid leukemia was started on induction therapy with cytarabine and idarubicin and presented 10 days after its initiation with rectorrhagia, melena and abnormal uterine bleeding. Due to clinical deterioration, she was transferred to the intensive care unit and required massive transfusion therapy. She needed angiotomography of the abdomen, with a probable area of active bleeding in the thin loop of the proximal jejunum, as well as contrasted resonance of the abdomen and pelvis, with multiple myomatosis and endometrial thickening. Abdominal arteriography was performed, requiring supra-selective embolization of the distal branch of the superior mesenteric artery supplying the jejunum. Subsequently, selective aorto-iliac arteriography was performed, proceeding to complete occlusion with coils of uterine arteries bilaterally. Post-procedure evolution, without new signs of bleeding. Imaging control ruled out complications. She completed the induction scheme and was discharged on the 45th day of hospitalization to continue the chemotherapy maintenance scheme on an outpatient basis. Early arteriography and embolization are viable, safe and effective procedures both for the management of gastrointestinal and uterine bleeding in patients with AML receiving induction therapy.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"45 2","pages":"192-197"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144838064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Perioperative and adjuvant chemotherapy on survival in advanced gastric cancer following gastrectomy with D2 lymphadenectomy]. [胃癌D2淋巴结切除术后围手术期及辅助化疗对生存的影响]。
Cesia J Luna-Córdova, Juan Alberto Díaz-Plasencia, Edgar Fermín Yan-Quiroz, José Richard Tenazoa-Villalobos

Objective: To describe the effectiveness of perioperative chemotherapy and adjuvant chemotherapy in the survival of patients with gastric carcinoma after gastrectomy with D2 lymphadenectomy (T2-T4a) and to determine the association between the intervening factors of the study and the survival of this group.

Materials and methods: Observational study, retrospective cohorts, in patients who received perioperative or adjuvant chemotherapy at a Peruvian cancer institute from January 2007 to December 2022. To determine actuarial survival, the Kaplan-Meier method and the log-rank test were used to compare 2 survival curves.

Results: A total population of 82 patients was evaluated, of which 46 received adjuvant chemotherapy and 36 perioperative chemotherapy, with the most commonly used regimen being CAPOX and EOX/EOX, respectively. Clinical characteristics did not significantly influence overall survival and only the primary tumor (T) had a statistically significant association, with T4a being more frequent in the perioperative chemotherapy group than in the adjuvant modality group (80.6% vs 47.8%; p=0.002). When comparing both therapeutic modalities, it was evident that patients who received perioperative chemotherapy had a longer survival at 5 years (53.2%), however, this was not statistically significant (p=0.230).

Conclusions: Perioperative chemotherapy presented greater survival compared to adjuvant chemotherapy at 12, 36 and 60 months; however, these differences were not statistically significant.

目的:探讨围手术期化疗及辅助化疗对胃癌D2淋巴结切除术(T2-T4a)后患者生存的影响,并确定本研究干预因素与该组患者生存的关系。材料和方法:观察性研究,回顾性队列,2007年1月至2022年12月在秘鲁癌症研究所接受围手术期或辅助化疗的患者。为确定精算生存率,采用Kaplan-Meier法和log-rank检验比较2条生存曲线。结果:共评估82例患者,其中辅助化疗46例,围手术期化疗36例,最常用的方案分别为CAPOX和EOX/EOX。临床特征对总生存率无显著影响,只有原发肿瘤(T)有统计学意义的相关性,围手术期化疗组T4a发生率高于辅助方式组(80.6% vs 47.8%;p = 0.002)。当比较两种治疗方式时,很明显,接受围手术期化疗的患者的5年生存率更长(53.2%),但这没有统计学意义(p=0.230)。结论:围手术期化疗在12个月、36个月和60个月的生存率高于辅助化疗;然而,这些差异没有统计学意义。
{"title":"[Perioperative and adjuvant chemotherapy on survival in advanced gastric cancer following gastrectomy with D2 lymphadenectomy].","authors":"Cesia J Luna-Córdova, Juan Alberto Díaz-Plasencia, Edgar Fermín Yan-Quiroz, José Richard Tenazoa-Villalobos","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To describe the effectiveness of perioperative chemotherapy and adjuvant chemotherapy in the survival of patients with gastric carcinoma after gastrectomy with D2 lymphadenectomy (T2-T4a) and to determine the association between the intervening factors of the study and the survival of this group.</p><p><strong>Materials and methods: </strong>Observational study, retrospective cohorts, in patients who received perioperative or adjuvant chemotherapy at a Peruvian cancer institute from January 2007 to December 2022. To determine actuarial survival, the Kaplan-Meier method and the log-rank test were used to compare 2 survival curves.</p><p><strong>Results: </strong>A total population of 82 patients was evaluated, of which 46 received adjuvant chemotherapy and 36 perioperative chemotherapy, with the most commonly used regimen being CAPOX and EOX/EOX, respectively. Clinical characteristics did not significantly influence overall survival and only the primary tumor (T) had a statistically significant association, with T4a being more frequent in the perioperative chemotherapy group than in the adjuvant modality group (80.6% vs 47.8%; p=0.002). When comparing both therapeutic modalities, it was evident that patients who received perioperative chemotherapy had a longer survival at 5 years (53.2%), however, this was not statistically significant (p=0.230).</p><p><strong>Conclusions: </strong>Perioperative chemotherapy presented greater survival compared to adjuvant chemotherapy at 12, 36 and 60 months; however, these differences were not statistically significant.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"45 2","pages":"139-146"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144838066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Intestinal ultrasound in inflammatory bowel disease: When and how use it efficiently?] 肠超声在炎症性肠病中的应用:何时以及如何有效使用?]
Viviana Parra Izquierdo, Hugo Cedron, Marjorie Argollo, Joana Torres, Kenneth Ernest-Suárez

In Latin America, the prevalence of Inflammatory Bowel Disease (IBD) has increased in recent years, creating a growing need for diagnostic tools both for its detection and for ongoing monitoring. Intestinal ultrasound (IUS) has become a well-established, non-invasive, accurate, and well-tolerated tool to evaluate IBD activity in real time-even during the same medical consultation. Available evidence supports its usefulness in accurately determining inflammatory activity and identifying associated complications. At the time of diagnosis and initiation of treatment, IUS has proven to be the ideal non-invasive study for close monitoring, assessing therapeutic response, and making early treatment adjustments. Multiple systematic reviews and meta-analyses have shown that its diagnostic accuracy is comparable to that of colonoscopy or magnetic resonance imaging. Additionally, IUS allows for therapeutic monitoring and prognosis assessment in a more accessible, non-invasive way, with greater patient adherence compared to other diagnostic modalities. This review article aims to analyze the optimal use of IUS and its current role in the management of patients with IBD.

近年来,在拉丁美洲,炎症性肠病(IBD)的患病率有所上升,这使得对诊断工具的需求日益增长,包括检测和持续监测。肠超声(IUS)已经成为一种完善的、无创的、准确的、耐受性良好的实时评估IBD活动的工具,甚至在同一次医疗咨询期间也是如此。现有证据支持其在准确确定炎症活动和识别相关并发症方面的有效性。在诊断和开始治疗时,IUS已被证明是密切监测、评估治疗反应和早期调整治疗的理想非侵入性研究。多个系统评价和荟萃分析表明,其诊断准确性与结肠镜检查或磁共振成像相当。此外,与其他诊断方式相比,IUS允许以更容易获得、非侵入性的方式进行治疗监测和预后评估,具有更高的患者依从性。这篇综述文章旨在分析IUS的最佳使用及其在IBD患者管理中的作用。
{"title":"[Intestinal ultrasound in inflammatory bowel disease: When and how use it efficiently?]","authors":"Viviana Parra Izquierdo, Hugo Cedron, Marjorie Argollo, Joana Torres, Kenneth Ernest-Suárez","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In Latin America, the prevalence of Inflammatory Bowel Disease (IBD) has increased in recent years, creating a growing need for diagnostic tools both for its detection and for ongoing monitoring. Intestinal ultrasound (IUS) has become a well-established, non-invasive, accurate, and well-tolerated tool to evaluate IBD activity in real time-even during the same medical consultation. Available evidence supports its usefulness in accurately determining inflammatory activity and identifying associated complications. At the time of diagnosis and initiation of treatment, IUS has proven to be the ideal non-invasive study for close monitoring, assessing therapeutic response, and making early treatment adjustments. Multiple systematic reviews and meta-analyses have shown that its diagnostic accuracy is comparable to that of colonoscopy or magnetic resonance imaging. Additionally, IUS allows for therapeutic monitoring and prognosis assessment in a more accessible, non-invasive way, with greater patient adherence compared to other diagnostic modalities. This review article aims to analyze the optimal use of IUS and its current role in the management of patients with IBD.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"45 2","pages":"155-175"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144838065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Vanek's tumor as an uncommon cause of digestive bleeding]. [Vanek肿瘤是消化道出血的罕见病因]。
Sergio Morínigo, Maisa Vallejos, Sebastián Díaz Duba, Sebastián Burró, Carolina Miranda, José Villarejo, Jesús Ortiz Villalba

Gastrointestinal tract polyps exhibit a wide range of characteristics, from benign to potentially malignant lesions. Vanek's polyp, a rare entity, is characterized by its inflammatory infiltrate and vascular alterations, often leading to confusion with adenomatous lesions. We present the case of a 77-year-old woman with a one-month history of rectal bleeding, requiring hospitalization during one of the episodes. Colonoscopy revealed a pedunculated polyp, which was resected without complications. Histopathological analysis showed a lymphoplasmacytic infiltrate, multiple vessels with fibrinoid necrosis, and no neoplastic atypia. Due to the nonspecific nature of the report, immunohistochemical studies were performed, revealing CD34 positivity in the vessels and vimentin positivity in mesenchymal cells. These findings suggest a differential diagnosis from inflammatory fibroid polyps. Vanek's polyps are uncommon lesions that require accurate diagnosis and appropriate management. Recent trends show an increase in the identification of these polyps, likely due to advancements in diagnostic techniques.

胃肠道息肉表现出广泛的特征,从良性到潜在的恶性病变。Vanek息肉是一种罕见的息肉,其特征是炎症浸润和血管改变,常与腺瘤性病变混淆。我们提出的情况下,一个77岁的妇女有一个月的直肠出血史,需要住院期间的发作之一。结肠镜检查发现有带蒂息肉,切除后无并发症。组织病理学分析显示淋巴浆细胞浸润,多支血管伴纤维蛋白样坏死,无肿瘤异型性。由于该报告的非特异性,我们进行了免疫组化研究,发现血管中CD34阳性,间充质细胞中vimentin阳性。这些发现提示与炎性肌瘤息肉的鉴别诊断。Vanek息肉是一种罕见的病变,需要准确的诊断和适当的治疗。最近的趋势表明,这些息肉的识别增加,可能是由于诊断技术的进步。
{"title":"[Vanek's tumor as an uncommon cause of digestive bleeding].","authors":"Sergio Morínigo, Maisa Vallejos, Sebastián Díaz Duba, Sebastián Burró, Carolina Miranda, José Villarejo, Jesús Ortiz Villalba","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Gastrointestinal tract polyps exhibit a wide range of characteristics, from benign to potentially malignant lesions. Vanek's polyp, a rare entity, is characterized by its inflammatory infiltrate and vascular alterations, often leading to confusion with adenomatous lesions. We present the case of a 77-year-old woman with a one-month history of rectal bleeding, requiring hospitalization during one of the episodes. Colonoscopy revealed a pedunculated polyp, which was resected without complications. Histopathological analysis showed a lymphoplasmacytic infiltrate, multiple vessels with fibrinoid necrosis, and no neoplastic atypia. Due to the nonspecific nature of the report, immunohistochemical studies were performed, revealing CD34 positivity in the vessels and vimentin positivity in mesenchymal cells. These findings suggest a differential diagnosis from inflammatory fibroid polyps. Vanek's polyps are uncommon lesions that require accurate diagnosis and appropriate management. Recent trends show an increase in the identification of these polyps, likely due to advancements in diagnostic techniques.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"45 2","pages":"184-187"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144838068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Frequency of juxtapapillary diverticulum detected during endoscopic retrograde cholangiopancreatography]. [内窥镜逆行胰胆管造影检查乳头旁憩室的频率]。
Yhonny Castillo Arrieta, Diego Castillo Ayala, José Romero Urdaneta, Rosargelis Parra Graterol, Luis Traviezo Valles

Introduction: The weakest part of the duodenal wall is the ampulla of Vater, since here the circular arrangement of the duodenal musculature is destructured to integrate the sphincter of Oddi. This characteristic could be the reason why most duodenal diverticula appear in the juxtapapillary region, even including the papilla inside.

Objective: The objective of the research was to determine the patients diagnosed with juxtapapillary diverticulum (JD) after endoscopic retrograde cholangiopancreatography (ERCP), who were confused with different previous diagnoses.

Materials and methods: Retrospective study with intentional sample, where ERCP was performed on a universe of 12,686 patients who were referred with different previous gastrointestinal pathologies, therefore, they required diagnosis or treatment with this procedure.

Results: Of the 12,686 patients who underwent ERCP, between 01/07/2014 and 28/06/2024, a total of 872 (6.9%) presented a confirmatory diagnosis of juxtapapillary diverticulum, a diagnosis that differed partially or totally from the one presented before the procedure.

Conclusions: The prevalence detected was one of the highest reported for Latin America. DY is generally asymptomatic, affecting mostly elderly patients, but when it is symptomatic, they present different signs and symptoms, which simulate a wide variety of diagnoses, where the clinical and previous imaging studies do not provide sufficient clues for a correct analysis, therefore, ERCP is the perfect tool for the timely diagnosis and treatment of DY, clearing previous diagnostic doubts.

简介:十二指肠壁最薄弱的部分是壶腹,因为在这里十二指肠肌肉组织的圆形排列被破坏,以整合Oddi括约肌。这一特点可能是大多数十二指肠憩室出现在乳头旁区,甚至包括其中的乳头的原因。目的:探讨内镜逆行胆管胰胆管造影(ERCP)后诊断为并置乳头憩室(JD)的患者与以往不同诊断的混淆情况。材料和方法:有意向样本的回顾性研究,对12686例既往有不同胃肠道病变的患者进行ERCP,因此,他们需要用这种方法进行诊断或治疗。结果:在2014年7月1日至2024年6月28日期间接受ERCP的12,686例患者中,共有872例(6.9%)确诊为乳头旁憩室,该诊断与术前的诊断部分或完全不同。结论:检测到的患病率是拉丁美洲报告的最高患病率之一。DY一般无症状,多为老年患者,但出现症状时表现出不同的体征和症状,模拟了多种诊断,临床和以往影像学研究并没有提供足够的线索进行正确的分析,因此,ERCP是及时诊断和治疗DY的完美工具,消除了以往的诊断疑虑。
{"title":"[Frequency of juxtapapillary diverticulum detected during endoscopic retrograde cholangiopancreatography].","authors":"Yhonny Castillo Arrieta, Diego Castillo Ayala, José Romero Urdaneta, Rosargelis Parra Graterol, Luis Traviezo Valles","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>The weakest part of the duodenal wall is the ampulla of Vater, since here the circular arrangement of the duodenal musculature is destructured to integrate the sphincter of Oddi. This characteristic could be the reason why most duodenal diverticula appear in the juxtapapillary region, even including the papilla inside.</p><p><strong>Objective: </strong>The objective of the research was to determine the patients diagnosed with juxtapapillary diverticulum (JD) after endoscopic retrograde cholangiopancreatography (ERCP), who were confused with different previous diagnoses.</p><p><strong>Materials and methods: </strong>Retrospective study with intentional sample, where ERCP was performed on a universe of 12,686 patients who were referred with different previous gastrointestinal pathologies, therefore, they required diagnosis or treatment with this procedure.</p><p><strong>Results: </strong>Of the 12,686 patients who underwent ERCP, between 01/07/2014 and 28/06/2024, a total of 872 (6.9%) presented a confirmatory diagnosis of juxtapapillary diverticulum, a diagnosis that differed partially or totally from the one presented before the procedure.</p><p><strong>Conclusions: </strong>The prevalence detected was one of the highest reported for Latin America. DY is generally asymptomatic, affecting mostly elderly patients, but when it is symptomatic, they present different signs and symptoms, which simulate a wide variety of diagnoses, where the clinical and previous imaging studies do not provide sufficient clues for a correct analysis, therefore, ERCP is the perfect tool for the timely diagnosis and treatment of DY, clearing previous diagnostic doubts.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"45 2","pages":"147-154"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144838062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Certification and skill: the foundations of competence in gastroenterology]. [认证和技能:胃肠病学能力的基础]。
Hugo Guillermo Cedrón Cheng
{"title":"[Certification and skill: the foundations of competence in gastroenterology].","authors":"Hugo Guillermo Cedrón Cheng","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"45 1","pages":"5-7"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Gastric cancer screening in Chile. Results of the National Health Survey 2016-2017]. [智利的胃癌筛查。2016-2017年全国健康调查结果[d]。
Oscar Corsi Sotelo, Eduardo Fuentes-López, Gonzalo Latorre Selvat, Manuel A Espinoza Sepúlveda, Paula Margozzini Maira, Hugo Monrroy Bravo, Alberto Espino Espino, Arnoldo Riquelme Pérez

Introduction: Gastric cancer (GC) is the leading cause of oncologic death in Chile. Since 2006, the health authority has recommended upper gastrointestinal endoscopy (UGE) for symptomatic individuals ≥40 years old. In 2010, the UGE coverage in this group was estimated at 14%.

Objective: To evaluate UGE coverage for GC screening in Chile using data from the National Health Survey (NHS) 2016-17.

Materials and methods: The NHS 2016-17 surveyed 6,233 adults about the presence of persistent epigastric pain, possible upper gastrointestinal bleeding, and UGE. UGE prevalences among different groups were compared, and multivariate models adjusted for sex, age, income, education, area of residence, and belonging to an indigenous group were constructed.

Results: Both persistent epigastric pain and possible upper gastrointestinal bleeding were reported by 4.7%, being higher in the ≥ 40-year-old group and lower educational level. The prevalence of UGE performed at least once in life reached 20.8%, being higher in women, ≥40 years old, privately insured individuals, and the non-indigenous Hispanic population. The coverage of UGE in the last year among symptomatic individuals ≥40 years old increased to 19.8%, with no significant differences in the multivariate analysis.

Conclusion: The coverage of UGE in the last year in symptomatic individuals ≥40 years old for GC screening in Chile is 19.8%. Lowest socioeconomic status and indigenous peoples are disadvantaged groups.

简介:胃癌(GC)是智利肿瘤死亡的主要原因。自2006年以来,卫生当局建议≥40岁有症状的个体进行上消化道内窥镜检查(UGE)。2010年,该群体的UGE覆盖率估计为14%。目的:利用2016-17年国民健康调查(NHS)的数据评估智利GC筛查的UGE覆盖率。材料和方法:2016-17年NHS调查了6233名成年人关于持续性胃脘痛、可能的上消化道出血和UGE的存在。比较了不同人群的UGE患病率,并构建了调整了性别、年龄、收入、教育程度、居住地区和土著群体的多变量模型。结果:持续胃脘痛和可能的上消化道出血发生率为4.7%,其中年龄≥40岁组和文化程度较低组发生率较高。一生中至少进行一次UGE的患病率达到20.8%,在女性、≥40岁、私人保险个人和非土著西班牙裔人群中较高。≥40岁有症状个体去年UGE覆盖率上升至19.8%,多因素分析差异无统计学意义。结论:智利有症状的≥40岁人群中,最近一年的UGE筛查覆盖率为19.8%。社会经济地位最低和土著人民是弱势群体。
{"title":"[Gastric cancer screening in Chile. Results of the National Health Survey 2016-2017].","authors":"Oscar Corsi Sotelo, Eduardo Fuentes-López, Gonzalo Latorre Selvat, Manuel A Espinoza Sepúlveda, Paula Margozzini Maira, Hugo Monrroy Bravo, Alberto Espino Espino, Arnoldo Riquelme Pérez","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Gastric cancer (GC) is the leading cause of oncologic death in Chile. Since 2006, the health authority has recommended upper gastrointestinal endoscopy (UGE) for symptomatic individuals ≥40 years old. In 2010, the UGE coverage in this group was estimated at 14%.</p><p><strong>Objective: </strong>To evaluate UGE coverage for GC screening in Chile using data from the National Health Survey (NHS) 2016-17.</p><p><strong>Materials and methods: </strong>The NHS 2016-17 surveyed 6,233 adults about the presence of persistent epigastric pain, possible upper gastrointestinal bleeding, and UGE. UGE prevalences among different groups were compared, and multivariate models adjusted for sex, age, income, education, area of residence, and belonging to an indigenous group were constructed.</p><p><strong>Results: </strong>Both persistent epigastric pain and possible upper gastrointestinal bleeding were reported by 4.7%, being higher in the ≥ 40-year-old group and lower educational level. The prevalence of UGE performed at least once in life reached 20.8%, being higher in women, ≥40 years old, privately insured individuals, and the non-indigenous Hispanic population. The coverage of UGE in the last year among symptomatic individuals ≥40 years old increased to 19.8%, with no significant differences in the multivariate analysis.</p><p><strong>Conclusion: </strong>The coverage of UGE in the last year in symptomatic individuals ≥40 years old for GC screening in Chile is 19.8%. Lowest socioeconomic status and indigenous peoples are disadvantaged groups.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"45 1","pages":"24-31"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Potassium-competitive acid blockers: state of the art]. [钾竞争性酸阻滞剂:最新进展]。
José Augusto Urrego, William Otero, Hugo Cedrón, Hernando Marulanda, Alejandro Piscoya, Juan Sebastián Frías-Ordoñez, Lina Otero

Potassium-competitive acid blockers (PCABs) constitute an emerging class of drugs for the treatment of acid-related disorders. They represent an alternative to proton pump inhibitors (PPIs), which have been the standard therapy but present certain limitations. Currently, PCABs are available in Latin America and offer a promising therapeutic option. This review compares both drug classes across various key aspects. Potassium-competitive acid blockers (PCABs) offer significant advantages over proton pump inhibitors (PPIs) in terms of speed of action, potency, and duration of acid suppression, as well as efficacy in the treatment of erosive esophagitis and Helicobacter pylori eradication, among other aspects. Additionally, they exhibit lower interindividual variability. Currently, PCABs are available in Latin America and represent a promising therapeutic option. This review compares both drug classes across various key aspects.

钾竞争酸阻滞剂(PCABs)是一类用于治疗酸相关疾病的新兴药物。它们代表了质子泵抑制剂(PPIs)的替代方案,质子泵抑制剂一直是标准治疗,但存在一定的局限性。目前,pcab在拉丁美洲可用,并提供了一种有希望的治疗选择。这篇综述比较了两类药物在各个关键方面的差异。钾竞争性酸阻滞剂(PCABs)在作用速度、效力和抑酸持续时间以及治疗糜烂性食管炎和根除幽门螺杆菌等方面比质子泵抑制剂(PPIs)具有显著优势。此外,它们表现出较低的个体间变异性。目前,pcab在拉丁美洲是一种很有前景的治疗选择。这篇综述比较了两类药物在各个关键方面的差异。
{"title":"[Potassium-competitive acid blockers: state of the art].","authors":"José Augusto Urrego, William Otero, Hugo Cedrón, Hernando Marulanda, Alejandro Piscoya, Juan Sebastián Frías-Ordoñez, Lina Otero","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Potassium-competitive acid blockers (PCABs) constitute an emerging class of drugs for the treatment of acid-related disorders. They represent an alternative to proton pump inhibitors (PPIs), which have been the standard therapy but present certain limitations. Currently, PCABs are available in Latin America and offer a promising therapeutic option. This review compares both drug classes across various key aspects. Potassium-competitive acid blockers (PCABs) offer significant advantages over proton pump inhibitors (PPIs) in terms of speed of action, potency, and duration of acid suppression, as well as efficacy in the treatment of erosive esophagitis and Helicobacter pylori eradication, among other aspects. Additionally, they exhibit lower interindividual variability. Currently, PCABs are available in Latin America and represent a promising therapeutic option. This review compares both drug classes across various key aspects.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"45 1","pages":"38-55"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pre-procedure endoscopic features associated with difficult cannulation in endoscopic retrograde cholangiopancreatography in a referral hospital in Lima, Peru]. [秘鲁利马一家转诊医院内窥镜逆行胆管造影术前内镜特征与插管困难相关]。
Wilmer Gustavo Quiroga-Purizaca, Diego Ricardo Páucar-Aguilar, Emma Calderón-Yeren, Daniel Andrei Vargas-Blácido

Introduction: Several variables have been studied to predict difficult cannulation during endoscopic retrograde cholangiopancreatography (ERCP), but none have been identified that can effectively predict this difficulty and help make decisions to prevent complications.

Objectives: To determine whether endoscopic variables of the duodenal papilla, as well as the sign of bile aspiration, are associated with difficult cannulation during ERCP.

Materials and methods: A prospective and analytical study that included 203 patients who underwent ERCP, establishing an association between the type of duodenal papilla, location, presence of periampullary diverticulum and the sign of bile aspiration, and difficult cannulation.

Results: 140 (69.97%) women and 63 (31.03%) men were included, with an average age of 54.35 years. Difficult cannulation criteria were present in 32.51% of patients. Type 1 duodenal papilla had a lower rate of difficult cannulation, while types 3 and 4 had a higher cannulation difficulty (OR=1.89, 95% CI: 1.01-3.54 and OR=4.37, 95% CI: 1.54-12.4 respectively). The distal location of the duodenal papilla had an OR=1.32 for difficult cannulation, while the presence of a periampullary diverticulum had an OR=0.54 and the endoscopic sign of bile aspiration OR=0.9, without being statistically significant.

Conclusion: Types 3 and 4 duodenal papilla are significantly associated with difficult cannulation. The location of the papilla, as well as the presence of a periampullary diverticulum and bile aspiration, are not significantly associated with difficult cannulation.

已经研究了几个变量来预测内镜逆行胆管造影(ERCP)中插管困难的情况,但没有一个变量可以有效预测这种困难并帮助做出预防并发症的决定。目的:确定内镜下十二指肠乳头的变量,以及胆汁吸入的迹象,是否与ERCP期间插管困难有关。材料和方法:一项前瞻性和分析性研究,包括203例接受ERCP的患者,建立了十二指肠乳头的类型、位置、壶腹周围憩室的存在、胆汁吸入体征和插管困难之间的关系。结果:女性140例(69.97%),男性63例(31.03%),平均年龄54.35岁。32.51%的患者存在插管标准困难。1型十二指肠乳头插管困难率较低,3型和4型十二指肠乳头插管困难率较高(OR=1.89, 95% CI: 1.01 ~ 3.54; OR=4.37, 95% CI: 1.54 ~ 12.4)。十二指肠乳头远端位置插管困难的OR=1.32,壶腹周围憩室存在的OR=0.54,内镜下胆汁吸入征象OR=0.9,均无统计学意义。结论:3型和4型十二指肠乳头插管困难。乳头的位置、壶腹周围憩室的存在和胆汁吸进与插管困难没有明显的关系。
{"title":"[Pre-procedure endoscopic features associated with difficult cannulation in endoscopic retrograde cholangiopancreatography in a referral hospital in Lima, Peru].","authors":"Wilmer Gustavo Quiroga-Purizaca, Diego Ricardo Páucar-Aguilar, Emma Calderón-Yeren, Daniel Andrei Vargas-Blácido","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Several variables have been studied to predict difficult cannulation during endoscopic retrograde cholangiopancreatography (ERCP), but none have been identified that can effectively predict this difficulty and help make decisions to prevent complications.</p><p><strong>Objectives: </strong>To determine whether endoscopic variables of the duodenal papilla, as well as the sign of bile aspiration, are associated with difficult cannulation during ERCP.</p><p><strong>Materials and methods: </strong>A prospective and analytical study that included 203 patients who underwent ERCP, establishing an association between the type of duodenal papilla, location, presence of periampullary diverticulum and the sign of bile aspiration, and difficult cannulation.</p><p><strong>Results: </strong>140 (69.97%) women and 63 (31.03%) men were included, with an average age of 54.35 years. Difficult cannulation criteria were present in 32.51% of patients. Type 1 duodenal papilla had a lower rate of difficult cannulation, while types 3 and 4 had a higher cannulation difficulty (OR=1.89, 95% CI: 1.01-3.54 and OR=4.37, 95% CI: 1.54-12.4 respectively). The distal location of the duodenal papilla had an OR=1.32 for difficult cannulation, while the presence of a periampullary diverticulum had an OR=0.54 and the endoscopic sign of bile aspiration OR=0.9, without being statistically significant.</p><p><strong>Conclusion: </strong>Types 3 and 4 duodenal papilla are significantly associated with difficult cannulation. The location of the papilla, as well as the presence of a periampullary diverticulum and bile aspiration, are not significantly associated with difficult cannulation.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"45 1","pages":"32-37"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Endoscopic transgastric retrograde cholangiopancreatography assisted by laparoscopy in a patient with gastric bypass]. [腹腔镜辅助下经胃逆行胆管造影1例]。
Carmelo Blasco, Carolina Miranda, Sergio Morinigo, Maisa Vallejos

Endoscopic procedures, currently, are characterized by being minimally invasive diagnostic and therapeutic methods, which allow the management of a wide number of pathologies and in the hands of a good operator, present few complications. Both traumatic and spontaneous splenic rupture is a rare entity, mainly associated with abdominal trauma or splenomegaly due to hematological diseases, respectively. Splenic rupture secondary to endoscopic studies is a complication with a mortality close to 5%, of which only 100 cases have been reported to date, none of them in Colombia. Thereafter is the case of a patient who, after an upper digestive endoscopy and colonoscopy, presented a splenic rupture, in whom the non-operative management initially proposed failed, requiring emergent splenectomy, with satisfactory results.

目前,内窥镜手术的特点是微创诊断和治疗方法,允许管理大量的病理,并且在一个好的操作员手中,很少出现并发症。外伤性脾破裂和自发性脾破裂都是一种罕见的疾病,主要与腹部创伤或血液学疾病引起的脾肿大有关。内窥镜检查后继发的脾破裂是一种死亡率接近5%的并发症,迄今为止仅报告了100例,其中没有一例发生在哥伦比亚。随后有一例患者在上消化道内窥镜和结肠镜检查后出现脾破裂,最初建议的非手术治疗失败,需要紧急脾切除术,结果令人满意。
{"title":"[Endoscopic transgastric retrograde cholangiopancreatography assisted by laparoscopy in a patient with gastric bypass].","authors":"Carmelo Blasco, Carolina Miranda, Sergio Morinigo, Maisa Vallejos","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Endoscopic procedures, currently, are characterized by being minimally invasive diagnostic and therapeutic methods, which allow the management of a wide number of pathologies and in the hands of a good operator, present few complications. Both traumatic and spontaneous splenic rupture is a rare entity, mainly associated with abdominal trauma or splenomegaly due to hematological diseases, respectively. Splenic rupture secondary to endoscopic studies is a complication with a mortality close to 5%, of which only 100 cases have been reported to date, none of them in Colombia. Thereafter is the case of a patient who, after an upper digestive endoscopy and colonoscopy, presented a splenic rupture, in whom the non-operative management initially proposed failed, requiring emergent splenectomy, with satisfactory results.</p>","PeriodicalId":35807,"journal":{"name":"Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru","volume":"45 1","pages":"75-78"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1